Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains

被引:11
作者
Azmi, Fazren [1 ,2 ]
Elliott, Alysha G. [3 ]
Khalil, Zeinab G. [3 ]
Hussein, Waleed M. [1 ]
Kavanagh, Angela [3 ]
Huang, Johnny X. [3 ]
Quezada, Michelle [3 ]
Blaskovich, Mark A. T. [3 ]
Capon, Robert J. [3 ]
Cooper, Matthew A.
Skwarczynski, Mariusz [1 ]
Toth, Istvan [1 ,3 ,4 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Natl Univ Malaysia, Fac Pharm, Kuala Lumpur, Malaysia
[3] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia
[4] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
关键词
antibacterial activity; Gram-positive bacteria; lipopeptides; multidrug resistant; nanoparticles; self-assembly; CATIONIC ANTIMICROBIAL PEPTIDES; GROUP-A STREPTOCOCCUS; VACCINE CANDIDATE; DRUG-DELIVERY; NANOPARTICLES; AMPHIPHILES; ABSORPTION; MECHANISMS; MEMBRANES; EPITOPE;
D O I
10.2217/nnm.15.137
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim: To explore the potential of de novo designed cyclic lipopeptides and its linear counterparts as antibacterial agents. Materials & methods: The lipopeptides were synthesized via solid-phase peptide synthesis and the cyclization was achieved by using succinic acid linker. The antimicrobial activities of the lipopeptides were evaluated in vitro against a variety selection of Gram-negative and Gram-positive bacteria including clinical isolates of multidrug-resistant strains. Results: The synthesized lipopeptides were able to self-assemble into nanoparticles in an aqueous environment, with three exhibiting potent antibacterial activity against Gram-positive bacteria, including clinically relevant multidrug-resistant bacteria. Conclusion: The lead compounds have the potential to be developed as new antibacterials that are effective against Gram-positive bacteria, including multidrug-resistant isolates.
引用
收藏
页码:3359 / 3371
页数:13
相关论文
共 48 条
[1]   Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates [J].
Abdel-Aal, Abu-Baker M. ;
Batzloff, Michael R. ;
Fujita, Yoshio ;
Barozzi, Nadia ;
Faria, Andres ;
Simerska, Pavia ;
Moyle, Peter M. ;
Good, Michael F. ;
Toth, Istvan .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (01) :167-172
[2]   Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature [J].
Arnison, Paul G. ;
Bibb, Mervyn J. ;
Bierbaum, Gabriele ;
Bowers, Albert A. ;
Bugni, Tim S. ;
Bulaj, Grzegorz ;
Camarero, Julio A. ;
Campopiano, Dominic J. ;
Challis, Gregory L. ;
Clardy, Jon ;
Cotter, Paul D. ;
Craik, David J. ;
Dawson, Michael ;
Dittmann, Elke ;
Donadio, Stefano ;
Dorrestein, Pieter C. ;
Entian, Karl-Dieter ;
Fischbach, Michael A. ;
Garavelli, John S. ;
Goeransson, Ulf ;
Gruber, Christian W. ;
Haft, Daniel H. ;
Hemscheidt, Thomas K. ;
Hertweck, Christian ;
Hill, Colin ;
Horswill, Alexander R. ;
Jaspars, Marcel ;
Kelly, Wendy L. ;
Klinman, Judith P. ;
Kuipers, Oscar P. ;
Link, A. James ;
Liu, Wen ;
Marahiel, Mohamed A. ;
Mitchell, Douglas A. ;
Moll, Gert N. ;
Moore, Bradley S. ;
Mueller, Rolf ;
Nair, Satish K. ;
Nes, Ingolf F. ;
Norris, Gillian E. ;
Olivera, Baldomero M. ;
Onaka, Hiroyasu ;
Patchett, Mark L. ;
Piel, Joern ;
Reaney, Martin J. T. ;
Rebuffat, Sylvie ;
Ross, R. Paul ;
Sahl, Hans-Georg ;
Schmidt, Eric W. ;
Selsted, Michael E. .
NATURAL PRODUCT REPORTS, 2013, 30 (01) :108-160
[3]   The antimicrobial peptide gramicidin S permeabilizes phospholipid bilayer membranes without forming discrete ion channels [J].
Ashrafuzzaman, Md. ;
Andersen, O. S. ;
McElhaney, R. N. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (12) :2814-2822
[4]   Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant [J].
Azmi, Fazren ;
Fuaad, Abdullah Al Hadi Ahmad ;
Giddam, Ashwini Kumar ;
Batzloff, Michael R. ;
Good, Michael F. ;
Skwarczynski, Mariusz ;
Toth, Istvan .
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (22) :6401-6408
[5]   Detergent-like actions of linear amphipathic cationic antimicrobial peptides [J].
Bechinger, Burkhard ;
Lohner, Karl .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09) :1529-1539
[6]   Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogue [J].
Blanchfield, Joanne T. ;
Gallagher, Oliver P. ;
Cros, Cecile ;
Lewis, Richard J. ;
Alewood, Paul F. ;
Toth, Istvan .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (01) :97-102
[7]   Vancomycin resistance: occurrence, mechanisms and strategies to combat it [J].
Boneca, IG ;
Chiosis, G .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (03) :311-328
[8]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[9]   Improved Protease Stability of the Antimicrobial Peptide Pin2 Substituted with D-Amino Acids [J].
Carmona, G. ;
Rodriguez, A. ;
Juarez, D. ;
Corzo, G. ;
Villegas, E. .
PROTEIN JOURNAL, 2013, 32 (06) :456-466
[10]   Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action [J].
Chan, David I. ;
Prenner, Elmar J. ;
Vogel, Hans J. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09) :1184-1202